Literature DB >> 11944966

Comparison of R128Q mutations in human, ovine, and chicken leptins.

Nina Raver1, Eyal Vardy, Oded Livnah, Rene Devos, Arieh Gertler.   

Abstract

Human leptin and its R128Q mutant, as well as the R128Q mutants of ovine and chicken leptins, were prepared, expressed in Escherichia coli, refolded, and purified to homogeneity yielding electrophoretically pure, over 95% monomeric protein. R128Q mutations did not change the binding properties to BAF/3 cells stably transfected with the long form of human leptin receptor compared, respectively, to non-mutated human, ovine, and chicken leptins. In contrast, the biological activity tested in a proliferation assay in the same cells was drastically changed. Human leptin R128Q lost its activity and even became a weak antagonist, whereas the activities of ovine and chicken leptins were reduced 25- and 80-fold. If dimerization models were applicable leptin receptor activation, the present results would suggest that site 2 of the hormone was impaired. Two models, the human growth hormone:human growth hormone receptor (hGH:hGHR) (1:2) and the granulocyte-colony stimulating factor:granulocyte-colony stimulating factor receptor (GCSF:GCSFR) (2:2) complexes, were used for modeling. Superimposing the leptin structure on the hGH and GCSF models in the complex structures did not indicate any role for R128 in receptor binding. This made it impossible to correlate the results shown in the present work with the currently available models. Therefore, leptin may bind its receptors in a manner different than those proposed until now.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11944966     DOI: 10.1006/gcen.2001.7766

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  8 in total

1.  Development and characterization of high affinity leptins and leptin antagonists.

Authors:  Michal Shpilman; Leonora Niv-Spector; Meirav Katz; Chen Varol; Gili Solomon; Michal Ayalon-Soffer; Eric Boder; Zamir Halpern; Eran Elinav; Arieh Gertler
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

Review 2.  The multifactorial role of leptin in driving the breast cancer microenvironment.

Authors:  Sebastiano Andò; Stefania Catalano
Journal:  Nat Rev Endocrinol       Date:  2011-11-15       Impact factor: 43.330

3.  Preparation of biologically active monomeric recombinant zebrafish (Danio rerio) and rainbow trout (Oncorhynchus mykiss) recombinant growth hormones.

Authors:  Ewa Ocłoń; Gili Solomon; Zvi Hayouka; Arieh Gertler
Journal:  Fish Physiol Biochem       Date:  2018-05-18       Impact factor: 2.794

4.  Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists.

Authors:  Leonora Niv-Spector; Dana Gonen-Berger; Isabelle Gourdou; Eva Biener; Eugene E Gussakovsky; Yackir Benomar; Krishnan V Ramanujan; Mohammed Taouis; Brian Herman; Isabelle Callebaut; Jean Djiane; Arieh Gertler
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

5.  Mapping leptin-interacting sites in recombinant leptin-binding domain (LBD) subcloned from chicken leptin receptor.

Authors:  L Niv-Spector; N Raver; M Friedman-Einat; J Grosclaude; E E Gussakovsky; O Livnah; A Gertler
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

6.  A peptide derived from the human leptin molecule is a potent inhibitor of the leptin receptor function in rabbit endometrial cells.

Authors:  Ruben Rene Gonzalez; Paul C Leavis
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

Review 7.  The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression.

Authors:  Sebastiano Andò; Ines Barone; Cinzia Giordano; Daniela Bonofiglio; Stefania Catalano
Journal:  Front Oncol       Date:  2014-11-26       Impact factor: 6.244

8.  Physiological concentrations of leptin do not affect human neutrophils.

Authors:  Vera M Kamp; Jeroen D Langereis; Corneli W van Aalst; Jan A van der Linden; Laurien H Ulfman; Leo Koenderman
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.